跳至主要内容
临床试验/ACTRN12615000536561
ACTRN12615000536561进行中(未招募)3 期

Pneumococcal polysaccharide vaccine versus Normal Saline for primary prevention of heart attacks and strokes in at-risk Australians aged 55-60

niversity of Newcastle0 个研究点目标入组 4,725 人开始时间: 2015年5月27日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
4,725

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
55 Years 至 60 Years(—)
性别
All

入选标准

  • Men and women aged 55-60 years with no known CVD events and two or more risk factors for CVD. Risk factors include hypercholesterolaemia, hypertension, elevated BMI, and elevated waist circumference.

排除标准

  • Previous pneumococcal vaccination, previous cardiovascular events and any other condition for which the use of the vaccine is indicated (as per the Australian Immunisation Handbook).

研究者

发起方
niversity of Newcastle

相似试验